Donate today to support women in science at Burnet and their work to unlock the vaginal microbiome and reduce risk of HIV infection and preterm birth for women around the world.
Improving the health of vulnerable communities and changing lives is at the heart of what we do and who we are.
We are attempting to understand the connection between chronic inflammation and cancer.
We are investigating how the products of inflammation from inflammatory leucocytes influence the development or function of cancer cells.
We have identified a number of surface molecules on cancer cells that are known to normally stimulate inflammatory cells. Of particular interest are the inflammatory Th17 cells which have a critical role in gut inflammation and usually protect against gut microbes.
However for reasons that are not clear in some situations, Th17 cells establish a chronically inflamed environment which is conducive to the development or persistence of cancer.
We are attempting to establish if there is a connection to cancer development or enhancement of existing cancer disease.
For any general enquiries relating to this project, please contact:
Head, Immune Therapies Group
To create and translate knowledge into better health, so no-one is left behind.
85 Commercial Road, Melbourne
VIC, 3004, Australia
Receive updates and IMPACT magazine.
Copyright © 2023 Burnet Institute. ABN: 49 007 349 984
This website was developed with the generous support of a donor.
Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung people and we offer our respects to their Elders past and present.
We recognise and respect the continuation of cultural, spiritual and educational practices of Aboriginal and Torres Strait Islander peoples of this land.
